Massachusetts Financial Services Co. MA Has $9.07 Million Position in Definitive Healthcare Corp. (NASDAQ:DH)

Massachusetts Financial Services Co. MA lessened its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 36.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,136,876 shares of the company's stock after selling 1,825,873 shares during the period. Massachusetts Financial Services Co. MA owned about 2.91% of Definitive Healthcare worth $9,066,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Definitive Healthcare by 20.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after acquiring an additional 3,496 shares during the last quarter. Canada Pension Plan Investment Board raised its position in Definitive Healthcare by 18.1% in the 4th quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company's stock worth $120,000 after purchasing an additional 4,500 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Definitive Healthcare by 6.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock worth $334,000 after buying an additional 4,748 shares in the last quarter. ProShare Advisors LLC boosted its position in Definitive Healthcare by 49.1% in the 4th quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock valued at $62,000 after buying an additional 4,943 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in Definitive Healthcare by 27.4% in the 4th quarter. Wells Fargo & Company MN now owns 31,297 shares of the company's stock valued at $129,000 after buying an additional 6,736 shares during the last quarter. Institutional investors own 98.67% of the company's stock.

Definitive Healthcare Stock Down 4.5%

DH opened at $3.84 on Friday. The stock's fifty day simple moving average is $3.68 and its 200 day simple moving average is $3.63. Definitive Healthcare Corp. has a 1-year low of $2.15 and a 1-year high of $6.16. The stock has a market cap of $570.78 million, a PE ratio of -0.87, a price-to-earnings-growth ratio of 6.46 and a beta of 1.64. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. The firm had revenue of $59.19 million during the quarter, compared to the consensus estimate of $56.20 million. Definitive Healthcare had a negative net margin of 206.05% and a positive return on equity of 3.69%. The business's revenue for the quarter was down 6.8% compared to the same quarter last year. During the same period last year, the business posted $0.08 earnings per share. As a group, research analysts expect that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

DH has been the topic of a number of analyst reports. The Goldman Sachs Group increased their price target on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a research note on Monday, May 12th. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, June 21st. Finally, BTIG Research cut Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Definitive Healthcare currently has a consensus rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.